Lexicon Pharmaceuticals (LXRX) Debt Ratio (2010 - 2026)

Lexicon Pharmaceuticals (LXRX) has 17 years of Debt Ratio data on file, last reported at 0.18 in Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.18, down 45.37% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.18 (down 45.37% YoY), and the FY2025 annual result was 0.29, down 13.14% from the prior year.
• Debt Ratio eased to 0.18 in Q1 2026 per LXRX's latest filing, from 0.29 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.43 in Q4 2023 and troughed at 0.12 in Q3 2022.
• A 5-year average of 0.27 and a median of 0.27 in 2025 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2022 and 2026: Debt Ratio jumped 209.35% in 2022, then sank 45.37% in 2026.
• A 5-year view of Debt Ratio shows it stood at 0.25 in 2022, then soared by 73.47% to 0.43 in 2023, then slipped by 22.51% to 0.34 in 2024, then slipped by 13.14% to 0.29 in 2025, then tumbled by 36.69% to 0.18 in 2026.
• Business Quant data shows LXRX's Debt Ratio at 0.18 in Q1 2026, 0.29 in Q4 2025, and 0.27 in Q3 2025.